The ternary complex of antithrombin-anhydrothrombin-heparin reveals the basis of inhibitor specificity
- PMID: 15311268
- DOI: 10.1038/nsmb810
The ternary complex of antithrombin-anhydrothrombin-heparin reveals the basis of inhibitor specificity
Abstract
Antithrombin, the principal physiological inhibitor of the blood coagulation proteinase thrombin, requires heparin as a cofactor. We report the crystal structure of the rate-determining encounter complex formed between antithrombin, anhydrothrombin and an optimal synthetic 16-mer oligosaccharide. The antithrombin reactive center loop projects from the serpin body and adopts a canonical conformation that makes extensive backbone and side chain contacts from P5 to P6' with thrombin's restrictive specificity pockets, including residues in the 60-loop. These contacts rationalize many earlier mutagenesis studies on thrombin specificity. The 16-mer oligosaccharide is just long enough to form the predicted bridge between the high-affinity pentasaccharide-binding site on antithrombin and the highly basic exosite 2 on thrombin, validating the design strategy for this synthetic heparin. The protein-protein and protein-oligosaccharide interactions together explain the basis for heparin activation of antithrombin as a thrombin inhibitor.
Similar articles
-
Structure of the antithrombin-thrombin-heparin ternary complex reveals the antithrombotic mechanism of heparin.Nat Struct Mol Biol. 2004 Sep;11(9):857-62. doi: 10.1038/nsmb811. Epub 2004 Aug 15. Nat Struct Mol Biol. 2004. PMID: 15311269
-
The role of Arg46 and Arg47 of antithrombin in heparin binding.Biochemistry. 1999 Aug 3;38(31):10196-204. doi: 10.1021/bi990686b. Biochemistry. 1999. PMID: 10433728
-
Mutagenesis studies toward understanding the mechanism of differential reactivity of factor Xa with the native and heparin-activated antithrombin.Biochemistry. 2004 Mar 16;43(10):2898-905. doi: 10.1021/bi036145a. Biochemistry. 2004. PMID: 15005625
-
The mechanisms of action of alpha- and beta-isoforms of antithrombin.Blood Coagul Fibrinolysis. 1998 Nov;9 Suppl 3:S7-10. Blood Coagul Fibrinolysis. 1998. PMID: 10102493 Review.
-
Chemical approaches to define the structure-activity relationship of heparin-like glycosaminoglycans.Chem Biol. 2005 Jul;12(7):731-56. doi: 10.1016/j.chembiol.2005.05.013. Chem Biol. 2005. PMID: 16039522 Review.
Cited by
-
Identification of proteoglycans as the APRIL-specific binding partners.J Exp Med. 2005 May 2;201(9):1375-83. doi: 10.1084/jem.20042309. Epub 2005 Apr 25. J Exp Med. 2005. PMID: 15851487 Free PMC article.
-
Heparan sulfate regulates VEGF165- and VEGF121-mediated vascular hyperpermeability.J Biol Chem. 2011 Jan 7;286(1):737-45. doi: 10.1074/jbc.M110.177006. Epub 2010 Oct 25. J Biol Chem. 2011. PMID: 20974861 Free PMC article.
-
The allosteric mechanism of activation of antithrombin as an inhibitor of factor IXa and factor Xa: heparin-independent full activation through mutations adjacent to helix D.J Biol Chem. 2013 Nov 22;288(47):33611-33619. doi: 10.1074/jbc.M113.510727. Epub 2013 Sep 25. J Biol Chem. 2013. PMID: 24068708 Free PMC article.
-
Characterization of the conformational alterations, reduced anticoagulant activity, and enhanced antiangiogenic activity of prelatent antithrombin.J Biol Chem. 2008 May 23;283(21):14417-29. doi: 10.1074/jbc.M710327200. Epub 2008 Mar 28. J Biol Chem. 2008. PMID: 18375953 Free PMC article.
-
Crystallization and crystallographic studies of kallistatin.Acta Crystallogr F Struct Biol Commun. 2015 Sep;71(Pt 9):1135-8. doi: 10.1107/S2053230X15012893. Epub 2015 Aug 25. Acta Crystallogr F Struct Biol Commun. 2015. PMID: 26323298 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous